[1]
|
Pourhanifeh, M.H., Abbaszadeh-Goudarzi, K., Goodarzi, M., et al. (2019) Resveratrol: A New Potential Therapeutic Agent for Melanoma? Current Medicinal Chemistry, 19, 1878-1886.
|
[2]
|
Czarnecki, D. (2014) The Incidence of Melanoma Is Increasing in the Susceptible Young Australian Population. Acta Dermato-Venereologica, 94, 539-541.
|
[3]
|
Wadt, K.A., Drzewiecki, K.T. and Gerdes, A.M. (2015) High Accuracy of Family History of Melanoma in Danish Melanoma Cases. Familial Cancer, 14, 609-613. https://doi.org/10.1007/s10689-015-9820-1
|
[4]
|
Xiao, Q., Ying, J., Qiao, Z., et al. (2020) Exogenous Hydrogen Sulfide Inhibits Human Melanoma Cell Development via Suppression of the PI3K/AKT/mTOR Pathway. Journal of Dermatological Science, 98, 26-34.
|
[5]
|
Stigall, L.E., Brodland, D.G. and Zitelli, J.A. (2016) The Use of Mohs Micrographic Surgery (MMS) for Melanoma in Situ (MIS) of the Trunk and Proximal Extremities. Journal of the American Academy of Dermatology, 75, 1015-1021.
|
[6]
|
Raigani, S., Cohen, S. and Boland, G.M. (2017) The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy. Current Oncology Reports, 19, Article No. 17. https://doi.org/10.1007/s11912-017-0575-8
|
[7]
|
中国医疗保健国际交流促进会华夏皮肤影像人工智能协作组, 中国医疗保健国际交流促进会皮肤科分会皮肤影像学组, 中国中西医结合学会皮肤性病专业委员会皮肤影像学组, 等. 中国皮肤恶性黑素瘤皮肤镜特征专家共识[J]. 中华皮肤科杂志, 2020, 53(6): 401-408. https://doi.org/10.35541/cjd.20190688
|
[8]
|
Koshenkov, V.P., Broucek, J. and Kaufman, H.L. (2016) Surgical Management of Melanoma. In: Kaufman, H. and Mehnert, J., Eds., Melanoma, Springer, Cham, 149-179. https://doi.org/10.1007/978-3-319-22539-5_6
|
[9]
|
Bodenham, D.C. (1968) A Study of 650 Observed Malignant Melanomas in the South-West Region. Annals of the Royal College of Surgeons of England, 43, 218-239.
|
[10]
|
Ascierto, P.A. (2015) Immunotherapies and Novel Combinations: The Focus of Advances in the Treatment of Melanoma. Cancer Immunology, Immunotherapy, 64, 271-274. https://doi.org/10.1007/s00262-014-1647-3
|
[11]
|
Kim, Y., Gil, J., Pla, I., et al. (2020) Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes. Cancers, 12, 767-789. https://doi.org/10.3390/cancers12030767
|
[12]
|
Grahovac, J., Srdić-Rajić, T., Francisco Santibañez, J., et al. (2019) Telmisartan Induces Melanoma Cell Apoptosis and Synergizes with Vemurafenib in Vitro by Altering Cell Bioenergetics. Cancer Biology & Medicine, 16, 247-263.
https://doi.org/10.20892/j.issn.2095-3941.2018.0375
|
[13]
|
Madorsky Rowdo, F.P., Barón, A., Gallagher, S.J., et al. (2020) Epigenetic Inhibitors Eliminate Senescent Melanoma BRAFV600E Cells that Survive Long-Term BRAF Inhibition. International Journal of Oncology, 56, 1429-1441.
https://doi.org/10.3892/ijo.2020.5031
|
[14]
|
Ide, M., Koba, S., Sueoka-Aragane, N., et al. (2017) Mutation Profile of B-Raf Gene Analyzed by Fully Automated System and Clinical Features in Japanese Melanoma Patients. Pathology and Oncology Research, 23, 181-188.
https://doi.org/10.1007/s12253-016-0121-2
|
[15]
|
Robert, C., Karaszewska, B., Schachter, J., et al. (2015) Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib. The New England Journal of Medicine, 372, 30-39. https://doi.org/10.1056/NEJMoa1412690
|
[16]
|
孙晓冉, 孙剑经, 张林西. 肿瘤多药耐药机制的研究进展[J]. 现代肿瘤医学, 2017, 25(1): 164-166.
https://doi.org/10.3969/j.issn.1672-4992.2017.01.045
|
[17]
|
Martin, S., Dudek-Perić, A.M., Maes, H., et al. (2015) Concurrent MEK and Autophagy Inhibition Is Required to Restore Cell Death Associated Danger-Signalling in Vemurafenib-Resistant Melanoma Cells. Biochemical Pharmacology, 93, 290-304. https://doi.org/10.1016/j.bcp.2014.12.003
|
[18]
|
Adhikari, M., Adhikari, B., Ghimire, B., et al. (2020) Cold Atmospheric Plasma and Silymarin Nanoemulsion Activate Autophagy in Human Melanoma Cells. International Journal of Molecular Sciences, 21, 1939-1955.
https://doi.org/10.3390/ijms21061939
|
[19]
|
Shang, Y.Y., Yu, N., Xia, L., et al. (2020) Augmentation of Danusertib’s Anticancer Activity against Melanoma by Blockage of Autophagy. Drug Delivery and Translational Research, 10, 136-145.
https://doi.org/10.1007/s13346-019-00668-5
|
[20]
|
Wang, L., Guo, W., Ma, J., et al. (2018) Aberrant SIRT6 Expression Contributes to Melanoma Growth: Role of the Autophagy Paradox and IGF-AKT Signaling. Autophagy, 14, 518-533.
https://doi.org/10.1080/15548627.2017.1384886
|
[21]
|
Barceló, C., Sisó, P., Maiques, O., et al. (2020) T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma. Journal of Investigative Dermatology, 140, 1253-1265.
https://doi.org/10.1016/j.jid.2019.11.014
|
[22]
|
崔丹蕊, 刘波, 刘伟. 细胞自噬与肿瘤发生关系的研究进展[J]. 中国科学(生命科学), 2015, 45(6): 593-603.
https://doi.org/10.1360/n052015-00107
|
[23]
|
Perera, R.M., Di Malta, C. and Ballabio, A. (2019) MiT/TFE Family of Transcription Factors, Lysosomes, and Cancer. Annual Review of Cancer Biology, 3, 203-222. https://doi.org/10.1146/annurev-cancerbio-030518-055835
|
[24]
|
许莲, 唐芬, 李玄, 等. mTOR信号通路与自噬在肿瘤中的研究进展[J]. 现代生物医学进展, 2016, 16(7): 1372-1374. https://doi.org/10.13241/j.cnki.pmb.2016.07.041
|
[25]
|
Han, W., Pan, H., Chen, Y., et al. (2010) EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotecteve Response in Human Lung Cancer Cells. Cancer Cells, 6, e18691. https://doi.org/10.1371/journal.pone.0018691
|
[26]
|
Yang, S., Xiao, X., Meng, X., et al. (2011) A Mechanism for Synergy with Combined mTOR and PI3 Kinase Inhibitors. PLoS ONE, 6, e26343. https://doi.org/10.1371/journal.pone.0026343
|
[27]
|
Herman-Antosiewicz, A., Johnson, D.E. and Singh, S.V. (2006) Sulforaphane Causes Autophagy to Inhibit Release of Cytochrome C and Apoptosis in Human Prostate Cancer Cells. Cancer Research, 66, 5828-5835.
https://doi.org/10.1158/0008-5472.CAN-06-0139
|
[28]
|
Valli, F., García Vior, M.C., Roguin, L.P., et al. (2020) Crosstalk between Oxidative Stress-Induced Apoptotic and Autophagic Signaling Pathways in Zn(II) Phthalocyanine Photodynamic Therapy of Melanoma. Free Radical Biology and Medicine, 152, 743-754. https://doi.org/10.1016/j.freeradbiomed.2020.01.018
|
[29]
|
Bao, Y., Ding, Z., Zhao, P., et al. (2020) Autophagy Inhibition Potentiates the Anti-EMT Effects of Alteronol through TGF-β/Smad3 Signaling in Melanoma Cells. Cell Death & Disease, 11, 223-232.
https://doi.org/10.1038/s41419-020-2419-y
|
[30]
|
Antunes, F., Pereira, G.J.S., Saito, R.F., et al. (2020) Effective Synergy of Sorafenib and Nutrient Shortage in Inducing Melanoma Cell Death through Energy Stress. Cells, 9, 640-657. https://doi.org/10.3390/cells9030640
|
[31]
|
Yu, Y., Xiang, N., Lin, M., et al. (2019) miR-26a Sensitizes Melanoma Cells to Dabrafenib via Targeting HMGB1-Dependent Autophagy Pathways. Drug Design, Development and Therapy, 13, 3717-3726.
https://doi.org/10.2147/DDDT.S225671
|
[32]
|
Nakamura, Y. and Fujisawa, Y. (2018) Diagnosis and Management of Acral Lentiginous Melanoma. Current Treatment Options in Oncology, 19, Article No. 42. https://doi.org/10.1007/s11864-018-0560-y
|
[33]
|
Guo, B., Zhang, Q., Wang, H., Chang, P. and Tao, K. (2018) KCNQ1OT1 Promotes Melanoma Growth and Metastasis. Aging, 10, 632-644. https://doi.org/10.18632/aging.101418
|
[34]
|
Lugović-Mihić, L., Ćesić, D., Vuković, P., Novak Bilić, G., Šitum, M. and Špoljar, S. (2019) Melanoma Development: Current Knowledge on Melanoma Pathogenesis. Acta Dermatovenerologica Croatica, 27, 163-168.
|